PATENT CLAIM ANALYSIS

Application Number: 16002364
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "137100"]

Abstract:
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.

Claim (Index 90):
A method of detecting FOLR1 expression in a sample comprising contacting said sample with an antibody, antigen-binding fragment thereof, or polypeptide comprises the VH CDR1-3 and VL CDR1-3 polypeptide sequences selected from the group consisting of:\n (a) SEQ ID NOs:3-8, respectively; (b) SEQ ID NOs:9-14, respectively; (c) SEQ ID NOs: 15-20, respectively; (d) SEQ ID NOs:21-26, respectively; (e) SEQ ID NOs: 3-5 and SEQ ID NOs: 59, 7, and 8, respectively; (f) SEQ ID NOs: 3, 60, and 5 and SEQ ID NOs: 6-8, respectively; (g) SEQ ID NOs: 3, 61, and 5 and SEQ ID NOs: 6-8, respectively; (h) SEQ ID NOs: 3, 60, and 5 and SEQ ID NOs: 59, 7, and 8, respectively; and (i) SEQ ID NOs: 3, 61, and 5 and SEQ ID NOs: 59, 7, and 8, respectively.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 94.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15473008', '14473828', '14921596', '15620117', '14015653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.772545717133818
- 35 USC 102 Novelty (BERT): 0.6426513745290635
- Combined Prediction Score: 0.7595562828733426
- Mean Citation Score: 555.782786
- Max Citation Score: 684.2430400000002
- Similarity Product: 549.5008146760943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test